Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
197A.T
BUYTAUNS LABORATORIES INC. · Healthcare · Japan · $326M · Avg Vol: $681K/d
67
StockRankQ
50
V
53
M
51
P/E (TTM)
14.1x
ROE
—
D/E
1.3x
Dividend %
5.4%
COMPANY DESCRIPTION
TAUNS Laboratories,Inc. engages in the development, manufacture, export/import, and sale of in vitro diagnostics and research reagents, and its intermediates in Japan and internationally.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|
| Revenue | 109M | 98M | 115M | 116M | 2.2% |
| EPS | 0.28 | 0.19 | 0.36 | 0.39 | 11.5% |
| Shares | 100M | 100M | 100M | 103M | +3.0% |
| Debt | 31M | 40M | 60M | 90M | 43.3% |
| Equity | 46M | 53M | 85M | 109M | 33.3% |
| Op CF | 67M | -20M | 62M | 43M | -13.9% |
| Inv CF | -17M | -10M | -26M | -58M | — |
| Fin CF | -23M | -2M | 15M | 14M | — |
Loading...
PRICE (1M)-3.6%
SMA 50SMA 200
Close
$3.06
RSI (14)
31.6
52W High
$3.67
From 52W High
0.8%
SCORE BREAKDOWN
Quality
50
ROIC
30.8%96.8
ROE
—N/A
GP/Assets
26.5%59.6
Op. Margin
45.8%97.7
FCF/Assets
—N/A
Piotroski
—55.7
Int. Cover
50.0x91.5
D/E Ratio
1.27x11.0
Current Ratio
1.44x23.5
Value
53
P/E (TTM)
14.1x76.1
EV/EBITDA
11.7x37.2
P/FCF
—N/A
P/B
2.8x42.4
P/S
3.5x52.0
Div Yield
5.4%92.8
Momentum
51
52W High %
83%78.9
RS 6M
-41%29.8
SMA 50/200
0.95x48.8
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—66.8
Q Growth
-14%29.0
FUNDAMENTALS
Market Cap
$326M
P/E (Forward)
7.7x
Gross Margin
64.9%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 197A.T are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 197A.T | TAUNS LABORATORIES INC.(you) | $326M | 67 | BUY |
| 262A.T | INTERMESTIC INC | $399M | 66 | BUY |
| 368A.T | KITAZATO CORPORATION | $294M | 86 | STRONG BUY |
| 5889.T | JAPAN EYEWEAR HOLDINGS CO LTD | $311M | 87 | STRONG BUY |
| 7780.T | Menicon Co., Ltd. | $757M | 73 | BUY |
| 3154.T | Medius Holdings Co., Ltd. | $117M | 71 | BUY |
| 7979.T | Shofu Inc. | $403M | 91 | STRONG BUY |
| 8086.T | Nipro Corporation | $1.8B | 69 | BUY |
| 7702.T | JMS Co.,Ltd. | $66M | 62 | HOLD |
| 7743.T | SEED Co.,Ltd. | $92M | 81 | STRONG BUY |
Peer medians: ROE 8.2% · P/E 15.6x · Gross margin 47.8%